Aortic TEVAR Fellowship

Aortic TEVAR Fellowship


  • Grant: €9,000
  • Location: TBC
  • Duration: In-hospital training over a four-six week period and attendance at four highly specialised courses.


The TEVAR Fellowship is sponsored by Terumo Aortic, a global medical device company dedicated to developing solutions for aortic and peripheral vascular disease.



The Aortic TEVAR Fellowship – in partnership with Terumo Aortic – offers the unique opportunity to acquire theoretical and practical knowledge on endovascular aortic treatment.

The knowledge and experience gained from this Fellowship will help you establish or support endovascular aortic treatment programmes at your home centre.

Fellowship overview

The Aortic TEVAR Fellowship includes a comprehensive education and training programme of five modules – four highly specialised courses that take place in London and Geneva alongside in-hospital training in one of several international, high volume aortic centres.

The specialised courses include lectures on aortic pathologies eligible for endovascular treatment, basic knowledge on catheter techniques, all steps of endovascular aortic treatment, potential complications and the results of endovascular treatment according to the current literature.

Fellows will meet and work with experienced cardiothoracic surgeons and participate in the daily routine of the aortic team as part of the in-house training; giving you the opportunity to practice the knowledge acquired during the theoretical courses.

The five modules are:

  • Module 1: Introduction to Aortic Surgery
  • Module 2: Fundamentals Endovascular Skills Course I
  • Module 3. Fundamentals Endovascular Skills Course II
  • Module 4: Skills Course
  • Module 5: In-hospital training in a high-volume aortic centre (four-week stay)

Throughout your Fellowship, you will also receive one-to-one support from the EACTS Fellowship Advisor to ensure you get the most out of this opportunity.

How the Aortic TEVAR Fellowship will advance your surgical education

Following completion of the Fellowship, you will be able to:

  • List aortic pathologies eligible for endovascular treatment
  • Plan an endovascular treatment according to computed tomography imaging
  • Perform fundamental endovascular procedures such as implantation of stent-graft in aortic aneurysm
  • Avoid the most common complications related to endovascular aortic treatment
  • List the indications for endovascular treatment of aortic aneurysm, acute dissection, chronic dissection, penetrating ulceration and aortic rupture
  • Perform measurement of the aorta according to computed tomography imaging using software allowing multiplanar reconstruction
  • Critically evaluate the landing zone for aortic stent-graft according to computed tomography imaging
  • Choose the most appropriate stent-graft according to aortic anatomy
  • Report on recommendations on aortic treatment as outlined in the current guidelines



We offer a €9,000 grant to help with this Fellowship’s associated living and travel costs. Additionally, EACTS will also contribute towards the cost of your attendance at the EACTS Annual Meeting (the largest cardiothoracic meeting in the world).


Application and Selection Criteria

Essential Criteria 

In order to apply for this Fellowship, you must:

  • Be an EACTS member with up-to-date membership payment
  • Be a Resident, Fellow or Surgeon within the first four years after training (specialty degree)
  • Be fluent in English  


Desirable criteria: 

  • Having experience in thoracic aorta surgery as an independent surgeon
  • Possessing vascular catheter skills
  • Having Endovascular facilities at your home centre
  • Possibility of applying the knowledge and abilities acquired during the fellowship in home practice
  • Being able to perform endovascular procedures at your home centre once the skills have been acquired


The following documents must be provided as part of your application:

  • Curriculum Vitae (CV)
  • Letter of interest detailing the way in which you meet the application criteria, your career aspirations along with your how you are in a position to apply the skills and knowledge obtained during the Fellowship in your own centre
  • Letter of support from head of training/department
  • Operative experience


Application guidance

Please ensure that all documents submitted are written in English, and that they are submitted either as word documents or PDF. We do not accept images or handwritten applications. We are unable to provide advice or guidance about visa applications, so please ensure that you understand the visa requirements before applying for this Fellowship.

Evaluation and feedback

Fellows will complete a report on their experience at the end of the Fellowship, which they will present during the EACTS Annual Meeting.


#EACTSLive Schedule

1430-1600 – Practical Approach to Challenging Aortic Valve Surgery

 1130-1215 – Presidential Address

0945-1115 – Da Vinci Session
1145-1324 – Trial Updates Session

Quick Links

Join the discussion

EACTS Live Schedule

The following sessions will be streamed live from the Auditorium at this years’ 32nd EACTS Annual Meeting.

A practical approach to aortic valve repair 

Professional Challenge

Moderator(s) : R. De PaulisRomeR. SádabaPamplona

To understand the  indications for aortic valve repair in patients with aortic regurgitation
To select the appropriate surgical treatment and technique in these patients
To discuss pitfalls and complications of these techniques and how to deal with them

14:15 – Guidelines: are they clear on indications and timing – J. SjogrenLund

14:30 – Echocardiography: how to give accurate indications to the surgeon – M. Van DyckWoluwe-Saint-Lambert

14:45 – Standard surgical steps to repair an aortic valve – live-in-a-box – M. BoodhwaniOttawa

15:05 – Standard surgical steps to repair a bicuspid valve – live-in-a-box – J. VojacekHradec Kralove

15:30 – Aortic valve leaflet reconstruction using autologous pericardium guided by virtual reality image evaluation of the aortic root – T. TedoriyaAgeoK. KamiyaAgeoY. GatateAgeoT. MiyauchiAgeoM. Fukuzumi, AgeoY. YasushiKawagoe

15:45 – BREAK

16:00 – When not to repair and what to do when the repair fails – live-in-a-box – J. BavariaPhiladelphia

16:15 – Unexpected complications in valve sparing – L. De KerchoveWoluwe-Saint-Lambert

16:30 – A critical appraisal of the need for annuloplasty – H.J. SchäfersHomburg/Saar

16:35 – What do we want to achieve to optimize the long-term results of a valve sparing procedure – L. GirardiNew York

16:40 – Whats the role for TAVI – D. HolzheyLeipzig

16:55 – Small cusp size is a limitation for aortic valve repair? – T. KomiyaKurashikiS. TakeshiKurashikiM. NonakaKurashiki-shiT. MatsuoKurashiki-shi

17:10 – Comparison of root hemodynamics and configuration after valve preserving root replacement in a pulsatile flow moc loop – M. SekiMibu-machiT. KuniharaTokyoK. IwasakiTokyoK. SasakiTokyoH. SekiYamatoH. FukudaMIbu-machi

Trial update – ART, IMPAG and MITRA FR & COAPT

Focus Session


Moderator(s) : N. FreemantleLondon, S. FremesToronto, S. WindeckerBern, S. LimBirmingham, J. BraunLeiden

Objectives :

This session is designed by the EACTS Analytical Support Unit, a collaboration with the Institute of Clinical Trials and Methodology at University College London, UK.

After presentation of the trials by the authors, an in-depth analysis of the methods and results by Professor Freemantle will be followed by a debate on implications for current practice and current and future research and extensive Q&A from the audience.


Part 1: The ART trial

10:00 The ART trial: definitive results – D. TaggartOxford

10:10 The trialist view – N. FreemantleLondon

10:15 Implications for current practice – S. FremesToronto

10:20 Discussion


Part 2: The IMPAG Trial

10:35 The IMPAG Trial – D. GlineurOttawa

10:50 Discussion


Part 3: MITRAFr and COAPT

11:00 MITRAFr and COAPT – J.-F. ObadiaLyon

11:10 The trialist view – N. FreemantleLondon

11:15 Discussion

Managing patients with multi-vessel disease in the modern era

Professional Challenge

Organizer(s) : Coronary Surgery

Moderator(s) : M. GaudinoNew YorkD. TaggartOxford 
Panellist(s) : O. BertrandLavalF. CreaRomeS. FremesTorontoC. SpadaccioGlasgowR. TranbaughNew YorkA. ZientaraZürich

Discuss the evidence on the medical, percutaneous and surgical management of patients with multivessel disease in an extended Heart Team setting

08:15 – The 2018 ESC/EACTS guidelines on myocardial revascularization – M. Sousa UvaLisboa
08:30 – Do we revascularize too much? The role of medical therapy – F. CreaRome
08:45 – New advances in PCIO. BertrandLaval
09:00 – Conduit selection: New evidence for an old story – M. GaudinoNew York
09:15 – CABG controversies: OPCABG, flowmeter, and more – S. FremesToronto
 09:30 – CABG vs PCI in acute coronary syndromes – S. HeadRotterdam
09:45 – BREAK
10:00 – Live heart team from the Catholic University of Rome – G. A. LanzaRomeM. MassettiRome
10:45 – Improving early outcomes after CABG – T. SchwannToledo
11:00 – The skeletons in the closet: graft failure, stroke, mediastinitis – F. BakaeenCleveland
11:15 – Coronary revascularization is a palliative procedure: importance of optimal medical therapy and follow-up – A. KulikBoca Raton

<iframe width=”560″ height=”315″ src=”” frameborder=”0″ allow=”accelerometer; autoplay; encrypted-media; gyroscope; picture-in-picture” allowfullscreen></iframe>